Komori
Governance4516Nippon Shinyaku Co.,Ltd.Pharmaceuticals

Independent Officer Notification Form

社外取締役4名と社外監査役2名の計6名を独立役員として届け出た。うち社外取締役の西真弓氏と社外監査役の原浩治氏が新任として記載されている。

Worth reading
33Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
6
People (independent officers)
Wording
Definitive
How definitive the wording is.

Governance structure

Number of independent officers6Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

社外取締役の西真弓氏および社外監査役の原浩治氏が新任として記載されている。独立役員6名を届け出ている。

Governance structure
ItemDetails
Number of independent officers6
Changes this time社外取締役の西真弓氏および社外監査役の原浩治氏が新任として記載されている。独立役員6名を届け出ている。
Items this document does not state (6)
Corporate Governance StructureNumber of directorsCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

定時株主総会において社外役員の選任議案が付議されるため。6名はいずれも独立役員の要件を満たし、一般株主との利益相反を生じるおそれがないため、独立役員に指定したとしている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Nippon Shinyaku Co.,Ltd. (4516) timely disclosure | Komori